Study | Country | Type of study | Population | n | Male/femal e | Agey | Age group | Confounde r | Outcome | Measure of effect | Measure of associati on | Quality score |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Kurtoglu et al. [24] | Turkey | Case–contr ol | Healthy | 581 | 259/322 | 5–18 | Prepubertal boys |  | BMI | r = 0.759; P <  0.001 | Pearson correlatio n; P-value | 7 |
SBP | r =  0.502; P <  0.001 | |||||||||||
DBP | r =  0.335; P <  0.001 | |||||||||||
WC | r = 0.820; P <  0.001 | |||||||||||
FBS | r = 0.172; P = 0.046 | |||||||||||
Insulin | r = 0.609; P <  0.001 | |||||||||||
TC | r = 0.302; P <  0.001 | |||||||||||
TG | r = 0.409; P <  0.001 | |||||||||||
HDL-C | r =− 0.166; P = 0.056 | |||||||||||
HOMA-IR | r = 0.619; P <  0.001 | |||||||||||
Pubertal boys | BMI | r = 0.774; P <  0.001 | ||||||||||
SBP | r = 0.452; P <  0.001 | |||||||||||
DBP | r = 0.472; P <  0.001 | |||||||||||
WC | r = 0.833; P <  0.001 | |||||||||||
FBS | r = 0.047; P = 0.650 | |||||||||||
Insulin | r = 0.325; P <  0.001 | |||||||||||
TC | r = 0.467; P <  0.001 | |||||||||||
TG | r = 0.380; P <  0.001 | |||||||||||
HDL-C | r = − 0.304; P <  0.001 | |||||||||||
HOMA-IR | r = 0.336; P = 0.001 | |||||||||||
Prepubertal girls | BMI | r = 0.783; P <  0.001 | ||||||||||
SBP | r = 0.396; P <  0.001 | |||||||||||
DBP | r = 0.317; P <  0.001 | |||||||||||
WC | r = 0.853; P <  0.001 | |||||||||||
FBS | r = 0.210; P = 0.031 | |||||||||||
Insulin | r = 0.416; P <  0.001 | |||||||||||
TC | r = 0.272; P = 0.005 | |||||||||||
TG | r = 0.208; P = 0.032 | |||||||||||
HDL-C | r = − 0.349; P <  0.001 | |||||||||||
HOMA-IR | r = 0.409; P <  0.001 | |||||||||||
Pubertal Girls | BMI | r = 0.778; P <  0.001 | ||||||||||
SBP | r = 0.268; P <  0.001 | |||||||||||
DBP | r = 0.193; P = 0.008 | |||||||||||
WC | r = 0.781; P <  0.001 | |||||||||||
FBS | r = 0.131; P = 0.074 | |||||||||||
Insulin | r = 0.455; P <  0.001 | |||||||||||
TC | r = 0.101; P = 0.170 | |||||||||||
TG | r = 0.201; P = 0.006 | |||||||||||
HDL-C | r =− 0.189; P = 0.010 | |||||||||||
HOMA-IR | r = 0.449; P <  0.001 | |||||||||||
Silva et al. [15] | Brazil | Cross-sectio nal | Healthy | 388 | 169/219 | 10–19 | Male | Body fat percentage and puberty | BMI Z score | 0.58; P <  0.001 | Adjusted Pearson correlatio n; P-value | 6 |
WC | 0.79; P <  0.001 | |||||||||||
SBP | 0.47; P <  0.001 | |||||||||||
DBP | 0.37; P <  0.001 | |||||||||||
 |  |  |  |  |  |  | Female | stage | FBS | − 0.08; P <  0.001 |  |  |
Fasting insulin | 0.29; P <  0.001 | |||||||||||
HOMA1-IR | 0.29; P <  0.001 | |||||||||||
TC | 0.08 | |||||||||||
LDL-C | 0.14 | |||||||||||
HDL-C | − 0.34; P <  0.001 | |||||||||||
TG | 0.23; P <  0.01 | |||||||||||
BMI Z score | 0.48; P <  0.001 | |||||||||||
WC | 0.64; P <  0.001 | |||||||||||
SBP | 0.28; P <  0.001 | |||||||||||
DBP | 0.18; P <  0.01 | |||||||||||
FBS | 0.08; | |||||||||||
Fasting insulin | 0.43; P <  0.001 | |||||||||||
HOMA1-IR | 0.41; P <  0.001 | |||||||||||
TC | 0.04; | |||||||||||
LDL-C | 0.09; | |||||||||||
HDL-C | − 0.24; P <  0.001 | |||||||||||
TG | 0.25; P <  0.001 | |||||||||||
Goncalves et al. [12] | Brazil | Cross sectio nal | Healthy | 260 | 129/131 | 10–14 | Total |  | Body fat | 0.51; P <  0.001 | Pearson correlatio n; P-value | 6 |
WC | 0.74; P <  0.001 | |||||||||||
Weight | 0.75; P <  0.001 | |||||||||||
BMI | 0.88; P <  0.001 | |||||||||||
Waist to height ratio | 0.41; P <  0.001 | |||||||||||
WHR | 0.14; P <  0.05 | |||||||||||
HOMA-IR | 0.35; P <  0.001 | |||||||||||
Fasting insulin | 0.36; P <  0.001 | |||||||||||
SBP | 0.62; P <  0.001 | |||||||||||
DBP | 0.29; P <  0.001 | |||||||||||
TC | − 0.27; P <  0.001 | |||||||||||
LDL-C | − 0.18; P <  0.05 | |||||||||||
HDL-C | − 0.27; P <  0.001 | |||||||||||
TG | 0.06; P <  0.001 | |||||||||||
Gomez-Arbelaez et al. [16] | Colombia | Cross-sectio nal | Healthy | 669 | 351/318 | 8–14 | Total | Age, gender and Tanner stage | FBS | 0.815 ±0.244; P = 0.001 | Adjusted Beta ± SE | 7 |
HDL-C | − 1.333 ± 0.384; P = 0.001 | |||||||||||
TG | 3.887 ± 1.014; P <  0.001 | |||||||||||
SBP | 1.719 ±0.205; P <  0.001 | |||||||||||
DBP | 1.305 ±0.173; | |||||||||||
 |  |  |  |  |  |  |  |  |  | P <  0.001 |  |  |
Insulin | 0.362 ±0.051; P <  0.001 | |||||||||||
HOMA-IR | 0.085 ±0.011; P <  0.001 | |||||||||||
Atwa et al. [42] | Egypt | Cross-sectio nal | Healthy | 2762 | 1327/1435 | 12–15 | Male |  | Weight | r = 0.68; P <  0.001 | Pearson correlation coefficient; p-value | 8 |
BMI | r = 0.67; P <  0.001 | |||||||||||
WC | r=0.72; P <  0.001 | |||||||||||
Female | Weight | r =  0.68; P <  0.001 | ||||||||||
BMI | r = 0.65; P <  0.001 | |||||||||||
WC | r = 0.63; P <  0.001 | |||||||||||
Pillai et al. [27] | India | Prospective observational cross-sectional | Women with PCOS | 121 | 0/121 | 12–41 | Female |  | WC | r = 0.758; p < 0.001 | Pearson correlation coefficients | 6 |
Vallianou et al. [44] | Greece | Cross-sectio nal | Consecutive adults who had visited the ‘Polykliniki’ GeneralHos pital for a health check-up | 490 | 194/296 | 18–89 |  | Age, gender, years of school, smoking, physical activity, diet, alcohol intake | SBP | 0.97 (0.41–1.54); p =  0.001 | Adjusted Beta (95% CI) | 7 |
DBP | 0.66 (0.31–1.01); P <  0.0001 | |||||||||||
FBS | 0.003 (0.001–0.005); p =  0.003 | |||||||||||
HDL-C | _1.37 (_1.77–0.97); p <  0.0001 | |||||||||||
LDL-C | 1.15 (_0.05–2.34); p = 0.06 | |||||||||||
TC | 1.01 (_0.33–2.35); p = 0.14 | |||||||||||
TG | 0.02 (0.01–0.03); p <  0.0001 | |||||||||||
Zepeda et al. [39] | USA | Cross-sectional | Healthy | 1058 | 561/497 | 6–18 | Male |  | WC | r =  0.78; P <  0.001 | Pearson correlation coefficients; p-value | 8 |
BMI | r = 0.72; P <  0.001 | |||||||||||
SBP | r =  0.44; P <  0.001 | |||||||||||
DBP | r = 0.23; P <  0.001 | |||||||||||
WHtR | r = 0.25; P <  0.001 | |||||||||||
Female | WC | r = 0.83; P <  0.001 | ||||||||||
BMI | r = 0.71; P <  0.001 | |||||||||||
SBP | r = 0.41; P <  0.001 | |||||||||||
DBP | r = 0.28; P <  0.001 | |||||||||||
WHtR | r =  0.49; P <  0.001 | |||||||||||
Luo et al. [11] | China | Cross- | Healthy | 1943 | 783/1160 | 58 ±7 | Male | Several | Trunk FM | 0.444; P <  0.001 | Adjusted | 8 |
 |  | sectional |  |  |  |  |  | metabolic and body fat parameter s | visceral fat area | 0.138; P <  0.001 | Beta; p-value |  |
Subcutaneous fat area | 0.208; P <  0.001 | |||||||||||
SBP | 0.052; P =  0.039 | |||||||||||
Female | Trunk FM | 0.519; P <  0.001 | ||||||||||
visceral fat area | 0.144; P <  0.001 | |||||||||||
Subcutaneous fat area | 0.053; P =  0.032 | |||||||||||
SBP | 0.098; P <  0.001 | |||||||||||
Lou et al. [41] | China | Cross-sectional | Healthy | 2847 | 1475/1372 | 7–12 | Male |  | Weight | r =  0.841; P <  0.001 | Pearson correlation coefficient; p-value | 8 |
BMI | r =  0.800; P <  0.001 | |||||||||||
WC | r =  0.809; P <  0.001 | |||||||||||
Female | Weight | r =  0.785; P <  0.001 | ||||||||||
BMI | r =  0.736; P <  0.001 | |||||||||||
WC | r =  0.739; P <  0.001 | |||||||||||
Selvan et al. [13] | India | Cross-sectio nal | Healthy | 451 | 258/193 | 30–80 | Male | Age | WC | r =  0.742; P <  0.001 | Adjusted Pearson correlation coefficient; p-value | |
BMI | r =  0.744; P <  0.001 | |||||||||||
SBP | r =  0.106 | |||||||||||
DBP | r =  0.113 | |||||||||||
FBS | r =  0.025 | |||||||||||
TC | r =  0211; P <  0.05 | |||||||||||
TG | r =  0.365; P <  0.001 | |||||||||||
LDL-C | r =  0.185 | |||||||||||
HDL-C | r =  = − 0.319; P <  0.01 | |||||||||||
Female | WC | r =  0.713; P <  0.001 | ||||||||||
BMI | r =  0.682; P <  0.01 | |||||||||||
SBP | r =  0.172 | |||||||||||
DBP | r =  0.028 | |||||||||||
FBS | r =  0.221 | |||||||||||
TC | r= 0.003 | |||||||||||
TG | r =  0.112 | |||||||||||
LDL-C | r =  =  0.092 | |||||||||||
HDL-C | r = -0.327; P <  0.01 | |||||||||||
Katz et al. [40] | Canada | Cross-sectional | Healthy | 1913 | 977/936 | 6–17 | Healthy-weight male | Age | BMI | 0.75 (0.62–0.88) | Adjusted Beta (95% CI) | 8 |
Overweight/ob ese male | BMI | 0.46 (0.38–0.54) | ||||||||||
Healthy-weight male | WC | 0.24 (0.18–0.3) | ||||||||||
Overweight/ob ese male | WC | 0.16 (0.13–0.18) | ||||||||||
Healthy-weight | BMI | 0.42 (0.37–0.47) | ||||||||||
 |  |  |  |  |  |  | female |  |  |  |  |  |
Overweight/ob ese female | BMI | 0.37 (0.26–0.48) | ||||||||||
Healthy-weight female | WC | 0.15 (0.12–0.17) | ||||||||||
Overweight/ob ese female | WC | 0.15 (0.13–0.17) | ||||||||||
Formisano et al. [23] | Italy, Belgium, Cyprus, Estonia, Germany, Hungary, Spain and Sweden | Cross-sectional | Healthy | 15673 | 7962/7711 | 3–10 | Boys | BMI z-score and country of origin | WC z-score | 0.318; P <  0.001 | Adjusted Pearson correlation coefficient; p-value | 8 |
SBPz-score | 0.030 | |||||||||||
DBP z-score | − 0.017 | |||||||||||
HDL-C z-score | − 0.060; P <  0.001 | |||||||||||
TG z-score | 0.056; P <  0.001 | |||||||||||
HOMA index z-score | 0.068; P <  0.001 | |||||||||||
Girls | WC z-score | 0.357; P <  0.001 | ||||||||||
SBPz-score | 0.050; P <  0.005 | |||||||||||
DBP z-score | − 0.011 | |||||||||||
HDL-C z-score | − 0.056; P <  0.005 | |||||||||||
TG z-score | 0.063; P <  0.001 | |||||||||||
HOMA index z-score | 0.111; P <  0.001 | |||||||||||
Cizza et al. [38] | USA | Cross-sectional | Obese | 120 | 28/92 | 18–50 | Total |  | MetS score | r =  0.458; p <  0.001 | Pearson correlation coefficient; p-value | 6 |
Fasting insulin | r =  0.476; P  <  0.001 | |||||||||||
HOMA index | r =  0.461; P <  0.001 | |||||||||||
Visceral fat | r =  0.674, P <  0.001 | |||||||||||
Subcutaneous fat | r =  0.125, P  =  0.20 | |||||||||||
Total abdominal fat% | r =  0.482, P <  0.001 | |||||||||||
Yang et al. [10] | China | Cross-sectional | Type 2 diabetic patients | 3182 | 1294/1888 | 20–80 | Male Female |  | BMI | r =  0.41; P < 0.0001 r = 0.84; P < 0.0001 | Pearson correlation coefficient; p-value | 8 |
Male Female |  | WC | r =  0.47; P <  0.0001 r = 0.47; P <  0.0001 | |||||||||
Kumar et al. [26] | India | Cross-sectional | Patients who attended medicine | 431 | 250/181 | Males  >  35 and females  > 40 | Total |  | BMI | 0.492; P  < 0.001 | Pearson correlation coefficient; | 7 |
WC | 0.453; P < 0.001 | |||||||||||
Hip | 0.458; P < 0.001 | |||||||||||
W/H RATIO | − 0.005; P  =  0.912 | |||||||||||
 |  |  | Clinic in a tertiary care KMC hospital |  |  |  |  |  | SBP | 0.243; P  < 0.001 | p-value |  |
DBP | 0.107; P=0.027 | |||||||||||
FBS | 0.166; P < 0.001 | |||||||||||
TC | 0.266; P < 0.001 | |||||||||||
LDL | 0.344; P < 0.001 | |||||||||||
HDL | − 0.173; P < 0.001 | |||||||||||
TG | 0.280; P  < 0.001 | |||||||||||
Rao et al. [46] | India | Cross-sectional | Patients who visited medicine OPD of a tertiary care teaching hospital | 250 | 180/70 | 40–100 | Total |  | SBP | 0.194056; P  =  0.002 | Pearson correlation coefficient; p-value | 6 |
DBP | 0.176716; P =  0.005 | |||||||||||
Li et al. [47] | China | Cross sectional | Patients who took lower abdomen and neck CT examination s | 177 | 87/90 | 35–75 | Men Women | Age | Visceral adipose tissue (VAT) | r  =  0.49, p < 0.00 r  =  0.25, p  =  0.012 | Adjusted Pearson correlation coefficient; p-value | 6 |
Men Women | Subcutaneous adipose tissue (SAT) | r  =  0.59, p <  0.001 r  =  0.41, p <  0.001 | ||||||||||
Zhou et al. [18] | China | Cross sectional | from the Examination Centre | 4201 | 2508/1693 | 20–85 | Male | Age | SBP | r =  0.250; p <  0.01 | Adjusted Pearson correlation coefficient; p-value | 8 |
DBP | r =  0.261; p <  0.01 | |||||||||||
FBG | r =  0.177; p <  0.01 | |||||||||||
TG | r =  0.240; p <  0.01 | |||||||||||
HDL-C | r =  − 0.202; p<0.01 | |||||||||||
TC | r = 0.143; p <  0.01 | |||||||||||
LDL-C | r =  0.088; p <  0.01 | |||||||||||
Female | SBP | r =  0.255; p <  0.01 | ||||||||||
DBP | r =  0.189; p <  0.01 | |||||||||||
FBG | r= 0.180; p <  0.01 | |||||||||||
TG | r =  0.199; p <  0.01 | |||||||||||
HDL-C | r =  − 0.234; p<0.01 | |||||||||||
TC | r =  0.039 | |||||||||||
LDL-C | r =  0.075; p <  0.01 | |||||||||||
Saka et al. [48] | Turkey | Cross-sectional | Healthy | 411 | 174/237 | 20–60 | Men Women |  | Body weight | r = 0.576; p=0.000 | Pearson correlation coefficient | 7 |
r = 0.702; p = 0.000 | ||||||||||||
Men Women | WC | r = 0.593; p = 0.000 | ||||||||||
r = 0.667; p = 0.000 | ||||||||||||
 |  |  |  |  |  |  | *Men Women |  | Hip circumferences | r = 0.568; p=0.000 r = 0.617; p = 0.000 |  |  |
Men Women | BMI | r=0.58; p = 0.000 r = 0.688; p = 0.000 | ||||||||||
Androutsos et al. [28] | Greece. | Cross-sectional | Healthy | 324 | 167/157 | 9–13 | Total | Age, gender, Tanner stage, physical activity, and protein-, carbohydrate- and fat-dietary intake | TC | − 0.200 ± 0.777 | Adjusted (β ± SE) | 7 |
HDL | − 1.713 ± 0.376 | |||||||||||
LDL | 1.016 ±0.669 | |||||||||||
Fasting glucose | 0.285 ±0.217 | |||||||||||
SBP | 2.082 ±0.273 | |||||||||||
DBP | 0.465 ±0.234 | |||||||||||
TG | 0.037 ±0.009 | |||||||||||
Insulin | 0.064 ±0.014 | |||||||||||
HOMA-IR | 0.067 ±0.014 | |||||||||||
Male |  | TC | r = − 0.11 | Pearson’s correlation coefficient | ||||||||
HDL | r = − 0.32, p<0.001 | |||||||||||
LDL | r = 0.04 | |||||||||||
FBS | r=0.10 | |||||||||||
SBP | r = 0.43, p < 0.001 | |||||||||||
DBP | r = 0.02 | |||||||||||
TG | r = 0.12 | |||||||||||
Insulin | r=0.23, p < 0.001 | |||||||||||
HOMA-IR | r = 0.23, p < 0.001 | |||||||||||
Female | TC | r = − 0.11 | ||||||||||
HDL | r = − 0.23, p<0.001 | |||||||||||
LDL | r = 0.05 | |||||||||||
FBS | r = 0.11 | |||||||||||
SBP | r=0.43, p < 0.001 | |||||||||||
DBP | r = 0.20,p < 0.05 | |||||||||||
TG | r=0.22, p < 0.05 | |||||||||||
Insulin | r = 0.35, p < 0.001 | |||||||||||
HOMA-IR | r = 0.36, p < 0.001 | |||||||||||
Total | TC | r =  = − 0.10 | ||||||||||
HDL | r = − 0.27, p<0.001 | |||||||||||
LDL | r =  = 0.01 | |||||||||||
FBS | r = 0.11 | |||||||||||
SBP | r = 0.43, p < 0.001 | |||||||||||
DBP | r = 0.09 | |||||||||||
TG | r = 0.15, p < 0.001 | |||||||||||
 |  |  |  |  |  |  |  |  | Insulin | r = 0.26, p < 0.001 |  |  |
HOMA-IR | r = 0.26, p < 0.001 | |||||||||||
Joshipura et al. [49] | San Juan, USA | Cross-sectional | Overweight/ obese, nondiabetic Hispanics | 1206 | 54.6% male | 40–65 | Total | Age, gender, smoking status, physical activity | BMI | R = 0.66; p < 0.001 | Adjusted Pearson correlation coefficient; p-value | 8 |
WC | R = 0.64; p < 0.001 | |||||||||||
% body fat | R = 0.45; p < 0.001 | |||||||||||
HOMA-IR | R = 0.45; p < 0.05 | |||||||||||
FBS | R = 0.10; p < 0.001 | |||||||||||
HbAlc | R = 0.28; p < 0.001 | |||||||||||
SBP | R = 0.18; p < 0.001 | |||||||||||
HDL-C | R = − 0.23; p<0.001 | |||||||||||
DBP | R = 0.23;p < 0.001 | |||||||||||
TG | R = 0.12; p < 0.05 | |||||||||||
Hs-CRP | R = 0.30; p <0.001 | |||||||||||
Hassan et al. [29] | Egypt | Cross-sectional case control | 50 healthy, 50 obese children | 100 | 52/48 | 7–12 | Metabolic subjects |  | Weight | 0.631;P = 0.001 | Pearson correlation coefficient; p-value | 6 |
BMI | 0.239; P = 0.240 | |||||||||||
WC | 0.465; P = 0.017 | |||||||||||
Waist/Hip | − 0.113; P = 0.582 | |||||||||||
SBP | 0.289; P = 0.152 | |||||||||||
DBP | 0.445; P = 0.023 | |||||||||||
LDL | 0.122; P = 0.551 | |||||||||||
HDL | − 0.120; P = 0.559 | |||||||||||
TC | 0.056;P =  0.787 | |||||||||||
TG | − 0.253; P = 0.212 | |||||||||||
FBS | − 0.377; P = 0.058 | |||||||||||
Fasting Insulin | 0.219; P = 0.283 | |||||||||||
HOMA-IR | 0.113;P =  0.583 | |||||||||||
Non metabolic subjects | Weight | 0.619; P =  0.001 | ||||||||||
BMI | 0.535;P =  0.007 | |||||||||||
WC | 0.605; P =  0.002 | |||||||||||
Waist/Hip | − 0.203; P =  0.340 | |||||||||||
SBP | 0.048; P =  0.823 | |||||||||||
DBP | 0.186; P =  0.384 | |||||||||||
LDL | − 0.444; P =  0.030 | |||||||||||
HDL | − 0.139; P =  0.516 | |||||||||||
TC | − 0.221; P =  0.299 | |||||||||||
TG | 0.314; P =  0.135 | |||||||||||
FBS | − 0.137; P =  0.524 | |||||||||||
Fasting Insulin | 0.119; P =  0.580 |  | ||||||||||
HOMA-IR | 0.116; P =  0.591 | |||||||||||
Cho et al.[19] | South | Conor | Healthy | 3521 | 1784/1737 | 42–71 | Male |  | SBP | 0.170; P < 0.001 | Pearson | 8 |
 | Korea | t |  |  |  |  |  |  | DBP | 0.200; P < 0.001 | Correlation coefficient; p-value |  |
BMI | 0.801; P < 0.001 | |||||||||||
WC | 0.740; P < 0.001 | |||||||||||
Body fat (%) | 0.547; P < 0.001 | |||||||||||
FPG | 0.159; P <  0.001 | |||||||||||
HOMA-IR | 0.317; P <  0.001 | |||||||||||
TG | 0.240; P <  0.001 | |||||||||||
HDL-C | − 0.246; P <  0.001 | |||||||||||
Female | SBP | 0.203; P <  0.001 | ||||||||||
DBP | 0.199; P <  0.001 | |||||||||||
BMI | 0.744; P <  0.001 | |||||||||||
WC | 0.706; P <  0.001 | |||||||||||
Body fat (%) | 0.510; P <  0.001 | |||||||||||
FPG | 0.122; P <  0.001 | |||||||||||
HOMA-IR | 0.234; P <  0.001 | |||||||||||
TG | 0.256; P <  0.001 | |||||||||||
HDL-C | − 0.223; P <  0.001 | |||||||||||
Guo et al. [43] | China | Cross-sectio nal | Normal | 6802 | 3631/3171 | 5–18 | Normal weight | Age, gender, BMI, WC | BMI | r = 0.226; P <  0.001 | Adjusted Pearson correlation coefficient; p-value | 8 |
WC | r = 0.339; P <  0.001 | |||||||||||
SBP | r = 0.449; P <  0.001 | |||||||||||
DBP | r = 0.328; P <  0.001 | |||||||||||
Overweight | BMI | r = 0.137; P <  0.001 | ||||||||||
WC | r = 0.348; P <  0.001 | |||||||||||
SBP | r = 0.459; P <  0.001 | |||||||||||
DBP | r = 0.344; P <  0.001 | |||||||||||
Obese | BMI | r = − 0.004;P =  0.932 | ||||||||||
WC | r = 0.635; P <  0.001 | |||||||||||
SBP | r = 0.477; P <  0.001 | |||||||||||
DBP | r = 0.325; P <  0.001 | |||||||||||
Hatipoglu et al. [25] | Turkey | Case–control | Overweight/ obese children and healthy ones as control | 967 | 475/492 | 6–18 | Boys prepubertal pubertal Girls prepubertal pubertal |  | BMI | r =  0.700; P < 0.001 r =  0.821; P < 0.001 r =  0.727; P < 0.001 r =  0.848; P<0.001 | Pearson correlation coefficient; p-value | 8 |
Boys Prepubertal Pubertal Girls Prepubertal Pubertal | WC | r =  0.733; P < 0.001 r =  0.839; P < 0.001 r =  0.776; P < 0.001 r =  0.854; P<0.001 |  | |||||||||
Kelishadi et al. [21] | Iran | Cross- | School | 23043 | 11708/113 | 6–18 | Male | Age, sex | Weight | r =  0.546; p <  0.001 | Adjusted | 7 |
 |  | sectional | students |  | 35 |  |  | and living area | BMI | r =  0.389; p < 0.001 | Pearson correlation coefficient; p-value |  |
WC | r =  0.491; p <  0.001 | |||||||||||
Waist/Hip | r =  0.035; p <  0.001 | |||||||||||
Waist/Height | r =  0.156; p <  0.001 | |||||||||||
Hip | r =  0.505; p <  0.001 | |||||||||||
Female | Weight | r =  0.481; p <  0.001 | ||||||||||
BMI | r =  0.387; p <  0.001 | |||||||||||
WC | r =  0.456; p <  0.001 | |||||||||||
Waist/Hip | r = − 0.020; p <  0.001 | |||||||||||
Waist/Height | r =  0.222; p <  0.001 | |||||||||||
Hip | r =  0.464; p <  0.001 | |||||||||||
Total | Weight | r =  0.519; p <  0.001 | ||||||||||
BMI | r =  0.384; p <  0.001 | |||||||||||
WC | r =  0.479; p <  0.001 | |||||||||||
Waist/Hip | r =  0.023; p <  0.001 | |||||||||||
Waist/Height | r =  0.188; p <  0.001 | |||||||||||
Hip | r =  0.478; p <  0.001 |